Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $587.18 million as of December 20, 2024. Its market cap has increased by 313.66% in one year.

Market Cap

587.18M

Enterprise Value

589.02M

Revenue

71.17M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.55

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 587.18M, an increase of 6,032.30%. That is a compound annual growth rate of 16.85%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	587.18M	313.03%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	52.63M	-31.72%
Dec 31, 2019	77.08M	25.51%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sandoz Group AG	18.23B
Telix Pharmaceuticals Limited	5.18B
Elekta AB (publ)	2.09B
Ryman Healthcare Limited	1.71B
Verano Holdings Corp.	471.76M
Vireo Growth Inc.	126.59M
Medexus Pharmaceuticals Inc.	48.37M

Market Cap Rankings